FAQ Library

FAQ Library published on August 26, 2015
Dr. Philip McCarthy explores the essential considerations that go into creating a survivorship plan for multiple myeloma.
FAQ Library published on June 4, 2015
Dr. Orlowski explains the difference between MRD and CR.
FAQ Library published on February 23, 2015
Dr. Stadtmauer discusses the role of the serum free light chain assay in the diagnostic workup for multiple myeloma.
FAQ Library published on December 18, 2014
The current standard of care and future DETERMINATION trial results for timing of transplantation in newly diagnosed multiple myeloma patients are discussed by Dr. Sergio Giralt.
FAQ Library published on November 6, 2014
Dr. Sagar Lonial describes how to define high-risk smoldering or asymptomatic multiple myeloma.
FAQ Library published on January 27, 2014 in Test/Monitoring
Dr. Raymond Comenzo explains deep sequencing PCR and what the investigational tool measures.
FAQ Library published on January 20, 2014 in Stem Cell Transplant
Dr. Raymond Comenzo explains stem cell stimulation, collection, and when it is appropriate to transplant in the treatment cycle of multiple myeloma patients.
FAQ Library published on November 6, 2013 in Clinical Trials
Dr. Philip McCarthy discusses the MM-020, or the FIRST study, looking at the superiority of an RD induction versus MPT and if RD only should be given for a fixed number of cycles or until progression.
FAQ Library published on September 17, 2013
Dr. Philippe Moreau discusses the role of serum free light chain assay for the detection and monitoring of multiple myeloma.
FAQ Library published on September 4, 2013
Dr. Philippe Moreau discusses diagnosing multiple myeloma in a patient that is not secreting proteins but presents with CRAB symptoms.
Page 6 of 13
Results 51 - 60 of 122